[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586572":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":40,"centralContacts":45,"locations":55,"responsibleParty":70,"collaborators":27,"id":73,"slug":27,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":27,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":95,"whyStopped":27,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"University of Puerto Rico","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard Postoperative opioid analgesia","ACTIVE_COMPARATOR","10 pills of 5mg oxycodone Q4hrs as needed",[13],"Drug: Oxycodone 5mg taken first",{"label":15,"type":16,"description":17,"interventionNames":18},"Postoperative Opioid-sparing Multimodal analgesia","EXPERIMENTAL","30 pills of 500mg acetaminophen Q4hrs and 30 pills of 500mg naproxen Q4hrs. Will also receive 5 tablets of 5mg oxycodone to take Q4hrs as needed for breakthrough pain",[19,20,21],"Drug: Acetaminophen","Drug: Naproxen Tablets, 500 mg","Drug: OxyCODONE 5 mg Oral Tablet",[23,28,32,36],{"type":24,"name":25,"description":11,"armGroupLabels":26,"otherNames":27},"DRUG","Oxycodone 5mg taken first",[9],null,{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"Acetaminophen","30 pills of 500mg acetaminophen Q4hrs",[15],{"type":24,"name":33,"description":34,"armGroupLabels":35,"otherNames":27},"Naproxen Tablets, 500 mg","30 pills of 500mg naproxen Q4hrs",[15],{"type":24,"name":37,"description":38,"armGroupLabels":39,"otherNames":27},"OxyCODONE 5 mg Oral Tablet","Only used for breakthrough pain",[15],[41],{"name":42,"affiliation":43,"role":44},"Christian A. Foy, MD","University of Puerto Rico Medical Sciences Campus","PRINCIPAL_INVESTIGATOR",[46,51],{"name":47,"role":48,"phone":49,"phoneExt":27,"email":50},"Jose I Acosta Julbe, MD","CONTACT","+1 7873794119","jose.acosta14@upr.edu",{"name":52,"role":48,"phone":53,"phoneExt":27,"email":54},"Daniel E. Deliz Jiménez, BSc","+1 7872332369","daniel.deliz@upr.edu",[56],{"facility":57,"status":27,"city":58,"state":59,"zip":60,"country":61,"countryCode":59,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"Oncological Hospital","San Juan","PR","00935","Puerto Rico",{"type":63,"coordinates":64},"Point",[65,66],-66.10572,18.46633,{"lat":66,"lon":65},[69],{"name":47,"role":48,"phone":49,"phoneExt":27,"email":50},{"type":44,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":27,"oldOrganization":27},"Daniel Deliz","Dr. Christian A. Foy","100586572",false,"NCT06917118","Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control Trial","WALANT","Inclusion Criteria:\n\n* Patients 21-70 years of age undergoing outpatient hand surgery\n* Patients undergoing surgery with WALANT technique\n* Patients who provide written informed consent\n\nExclusion Criteria:\n\n* Patients aged 20 and younger, or 71 and older\n* Patient with chronic pain requiring opioid use\n* Pregnant patients\n* Patients who do not self-identify as Hispanic\n* Patients with known allergy to the medication\n* Patients with contraindications for the prescribed medications","ALL","21 Years","70 Years",{"count":83,"type":84},100,"ESTIMATED","INTERVENTIONAL",[87],"NA","The main objective of the study is to measure the efficacy of a multimodal postoperative pain regimen consisting of oral acetaminophen and naproxen compared to a traditional opioid-only pain regimen following elective wide awake local anesthesia no tourniquet (WALANT) hand surgery in a Hispanic population. The study is a randomized control trial comparing the clinical outcomes of patients undergoing elective WALANT hand surgery performed by a board-certified, fellowship-trained orthopedic hand surgeon (Dr. Christian A. Foy).\n\nThe study groups are:\n\n* Control group: standard pain control with opioids\n* Experimental group: multimodal non-opioid pain control\n\nStudy Outcomes are:\n\n* VAS pain scores (7 days),\n* Total opioid usage\n* Patient satisfaction\n* Adverse events\n\nWe hypothesize that patients receiving multimodal pain regimens will report lower opioid use, lower pain scores, and greater satisfaction than patients receiving traditional opioid-only pain management.",[90],"Pain Management",[77,92,93,94],"Multimodal analgesia","Nonopioid pain management","VAS pain scores","NOT_YET_RECRUITING","2025-03-31",{"date":98,"type":99},"2025-04-08","ACTUAL",{"date":101,"type":84},"2025-05-01",{"date":103,"type":84},"2025-12-01",{"name":5,"class":6},1]